Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Enfermedad de Alzheimer y Demencias

8233 ARTÍCULOS , VIENDO DEL 4291 AL 4305

Methylphenidate for Apathy in Community-Dwelling Older Veterans With Mild Alzheimer's Disease: A Double-Blind, Randomized, Placebo-Controlled Trial

Padala PR, Padala KP, Lensing SY, Ramirez D, Monga V, Bopp MM, Roberson PK, Dennis RA, Petty F, Sullivan DH, Burke WJ.

Am J Psychiatry. 2018 Feb 1;175(2):159-168. doi: 10.1176/appi.ajp.2017.17030316. Epub 2017 Sep 15.

The value of subtraction MRI in detection of amyloid-related imaging abnormalities with oedema or effusion in Alzheimer's patients: An interobserver study

Martens RM, Bechten A, Ingala S, van Schijndel RA, Machado VB, de Jong MC, Sanchez E, Purcell D, Arrighi MH, Brashear RH, Wattjes MP, Barkhof F.

Eur Radiol. 2018 Mar;28(3):1215-1226. doi: 10.1007/s00330-017-5022-6. Epub 2017 Sep 27.

Prevalence of delusions in drug-naïve Alzheimer disease patients: A meta-analysis

Lai L, Lee PE, Chan P, Fok MC, Hsiung GR, Sepehry AA.

Int J Geriatr Psychiatry. 2019 Sep;34(9):1287-1293. doi: 10.1002/gps.4812. Epub 2017 Oct 11.

Older Adults with Alzheimer's Disease Who Have Used an Automatic Medication Dispenser for 3 or More Years

Kamimura T.

Clin Gerontol. 2019 Jan-Feb;42(1):127-133. doi: 10.1080/07317115.2017.1347594. Epub 2017 Oct 13.

Editorial: Alzheimer's Disease: From Molecular Mechanisms to Psychobiological Perspectives

Kamal MA, Greig NH.

Curr Alzheimer Res. 2017;14(11):1138-1139. doi: 10.2174/156720501411171006122827.

Placebo Effects in the Treatment of Noncognitive Symptoms of Alzheimer's Disease: Analysis of the CATIE-AD Data

Ozawa C, Roberts R, Yoshida K, Suzuki T, Lebowitz B, Reeves S, Howard R, Abe T, Mimura M, Uchida H.

J Clin Psychiatry. 2017 Nov/Dec;78(9):e1204-e1210. doi: 10.4088/JCP.17m11461.

[Development of SPECT Probes for In Vivo Imaging of β-Amyloid and Tau Aggregates in the Alzheimer's Disease Brain]

Watanabe H.

Yakugaku Zasshi. 2017;137(11):1361-1365. doi: 10.1248/yakushi.17-00156.

Nucleic Acid-Based Theranostics for Tackling Alzheimer's Disease

Chakravarthy M, Chen S, Dodd PR, Veedu RN.

Theranostics. 2017 Sep 5;7(16):3933-3947. doi: 10.7150/thno.21529. eCollection 2017.

Developing Disease-Modifying Treatments in Alzheimer's Disease - A Perspective from Roche and Genentech

Doody R.

J Prev Alzheimers Dis. 2017;4(4):264-272. doi: 10.14283/jpad.2017.40.

Clinical Effects of Tramiprosate in APOE4/4 Homozygous Patients with Mild Alzheimer's Disease Suggest Disease Modification Potential

Abushakra S, Porsteinsson A, Scheltens P, Sadowsky C, Vellas B, Cummings J, Gauthier S, Hey JA, Power A, Wang P, Shen L, Tolar M.

J Prev Alzheimers Dis. 2017;4(3):149-156. doi: 10.14283/jpad.2017.26.

Alzheimer's disease: An ignored condition

Lleó A.

Med Clin (Barc). 2018 Jun 8;150(11):432-433. doi: 10.1016/j.medcli.2017.10.028. Epub 2017 Nov 28.

The diagnosis of dementias: a practical tool not to miss rare causes

Ferrari C, Nacmias B, Sorbi S.

Neurol Sci. 2018 Apr;39(4):615-627. doi: 10.1007/s10072-017-3206-0. Epub 2017 Dec 2.

A phase III randomized trial of gantenerumab in prodromal Alzheimer's disease

Ostrowitzki S, Lasser RA, Dorflinger E, Scheltens P, Barkhof F, Nikolcheva T, Ashford E, Retout S, Hofmann C, Delmar P, Klein G, Andjelkovic M, Dubois B, Boada M, Blennow K, Santarelli L, Fontoura P; SCarlet RoAD Investigators.

Alzheimers Res Ther. 2017 Dec 8;9(1):95. doi: 10.1186/s13195-017-0318-y.

Blood-Brain Glucose Transfer in Alzheimer's disease: Effect of GLP-1 Analog Treatment

Gejl M, Brock B, Egefjord L, Vang K, Rungby J, Gjedde A.

Sci Rep. 2017 Dec 13;7(1):17490. doi: 10.1038/s41598-017-17718-y.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias